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Background. In order to reduce stroke risk, left atrial appendage amputation (LAAA) is widely adopted in recent years. The effect
of LAAA on left atrial (LA) function remains unknown. The objective of present study was to assess the effect of LAAA on LA
function. Methods. Sixteen patients with paroxysmal AF underwent thoracoscopic, surgical PVI with LAAA (LAAA group), and
were retrospectively matched with 16 patients who underwent the same procedure without LAA amputation (non-LAAA group).
To objectify LA function, transthoracic echocardiographywith 2D Speckle Trackingwas performed before surgery and at 12months
follow-up. Results. Mean age was 57 ± 9 years, 84% were male. Baseline characteristics did not differ significantly except for systolic
blood pressure (𝑝 = 0.005). In both groups, the contractile LA function and LA ejection fraction were not significantly reduced.
However, the conduit and reservoir function were significantly decreased at follow-up, compared to baseline. The reduction of
strain and strain rate was not significantly different between groups. Conclusions. In this retrospective, observational matched
group comparison with a convenience sample size of 16 patients, findings suggest that LAAA does not impair the contractile LA
function when compared to patients in which the appendage was unaddressed. However, the LA conduit and reservoir function
are reduced in both the LAAA and non-LAAA group. Our data suggest that the LAA can be removed without late LA functional
consequences.
1. Introduction
Atrial fibrillation (AF) has a major impact on health care in
theWestern population and is associatedwith poor prognosis
[1–3]. Besides widely adapted catheter ablation strategies for
AF, an emerging treatment strategy is surgical PVI [4, 5]. One
of the supposed advantages of this surgical approach is that
the LAA can be excluded to reduce stroke risk [6]. Although
beneficial effect on morbidity and mortality has not clearly
been demonstrated, the LAA is amputated or closed by a clip
on a large scale in stand-alone or concomitant AF surgery [7–
9].The effect of this amputation on left atrial function has not
been addressed in the current literature.
Current echocardiography guidelines actively recom-
mend the evaluation of LA function after AF to predict the
maintenance of sinus rhythm and also identify patients at
risk for LA failure or arrhythmias [10]. To assess this left
atrial function, recent techniques have been introduced such
as two-dimensional speckle tracking echocardiography (2D
STE), specifically the parameters strain and strain rate [10, 11].
These novel strain parameters aid to assess the different left
atrial functional stages: the reservoir function (storage of PV
inflow during ventricular systole), conduit function (passive
emptying during early diastole), and contractile function
(active emptying at late diastole) [11, 12]. The aim of this
study was to investigate the effects of left atrial appendage
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amputation on left atrial function in the setting of minimally
invasive surgical PVI.
2. Material and Methods
2.1. Patient Population. This observational and retrospective
matched group comparison was performed on two series
of consecutive patients who were treated for drug resis-
tant paroxysmal AF with sPVI between June 2009 and
November 2011 in two centers: Academic Medical Center
(AMC), Amsterdam, and UniversityMedical Center Gronin-
gen (UMCG) [13]. Patients were matched for gender, age,
LA diameter, and AF duration. Inclusion criteria were highly
symptomatic paroxysmal AF without concomitant cardiac
structural disease, refractory to class I and/or class III
AADs or failed catheter ablation for AF. Exclusion criteria
for surgical PVI were as follows: left atrial size > 60mm
(parasternal echocardiographic view), prior heart or lung
surgery, significant coronary disease or previous MI, left
ventricular hypertrophy > 12mm, previous hospitalization
for heart failure, moderate or severe mitral or aortic valve
disease, or lung disease (prior tuberculosis or COPD Gold
classes III-IV). Furthermore, patients with an ejection frac-
tion < 50% were excluded. Patients in AF or atrial flutter
at the time of the echocardiographic analysis were excluded
since sinus rhythm is mandatory to reliably objectify the
different phases of left atrial function. Definitions of AF,
adverse events, and follow-up monitoring were based on the
Heart Rhythm Society Consensus Statement for the catheter
and surgical ablation of AF [14]. Patients provided written
informed consent to the procedure. All patients were treated
according to the standard of care for surgical PVI procedures
in both AMC and UMCG, and no additional examinations
were performed. Clinical and echocardiography data was
collected retrospectively and patient privacy was granted
by coding of the database according to the rules of good
clinical practice and Dutch privacy law. Furthermore, all
echocardiography files were anonymized before analysis at
the University Medical Center Groningen, Netherlands.
2.2. Surgical Procedure. All patients were treated using
the video assisted, completely thoracoscopic approach, as
detailed previously by Krul et al. [15] and De Maat et al.
[13]. In brief, the pulmonary veins were targeted by bilateral
thoracoscopy. To isolate the pulmonary veins, a bipolar
radiofrequency clamp (Isolator, AtriCure, Inc., Cincinnati,
Ohio) was used to create a linear, transmural, thermal lesion.
Following the ablation, measurement of effective conduc-
tion block was performed by pacing within the PVs (exit
block). In the AMC series, also entry block was checked.
No additional linear ablations (ablation lines) were applied
on the atria. After effective isolation of both right and left
PVs, the left atrial appendage was addressed. Concerning
the left atrial appendage (LAA) management, in all patients
from the LAAA group (AMC) the LAA was amputated
with an endoscopic stapling device (Endo Gia stapler, Tyco
Healthcare Group, North Haven, CT) [15], whereas in the
non-LAAA (UMCG) group the appendage was intentionally
not addressed [13].
2.3. Echocardiographic Analysis. For this study, a protocol
for transthoracic echocardiographic measurement was com-
piled. In both centers, all patients underwent the echocar-
diographic analysis performed by experienced sonographers
following the protocol. Complete set of measurements are
described in Table 2. All images were stored digitally in a
DICOM format and stored for offline analysis. Offline anal-
ysis was performed by an experienced sonographer (YMH)
whowas blinded for all other subject characteristics including
surgical procedure (LAAA or non-LAAA group). Standard
2D measurements were performed using EchoPac BT12
(General Electric, Horton, Norway); 2D STE software was
utilized to analyze LA deformation. All measurements were
performed in accordance with the current echocardiographic
recommendations and guidelines [10, 11]. Volumetric calcu-
lation of both LV and LA was performed using Simpson’s
biplanemethod of discs. Additionally LA end systolic volume
was indexed to body surface area. Left atrial ejection fraction
was calculated as ((LAVmax − LAVmin)/LAVmax) ∗ 100 [16].
2.4. Two-Dimensional Speckle Tracking Echocardiography.
For the strain measurements, the apical four-chamber view
was utilized. As depicted in Figure 1, the edge of the LA
endocardium was manually traced after which the software
automatically generated tracings based on the speckles of
the 2D image. The tracing was all inspected for correctness
and manually adjusted if needed and accepted if tracing
was acceptable. The software then calculated the mean
deformation (strain) expressed in a percentage and speed
of deformation (strain rate) expressed as 1/s of the speckles
within the region of interest.
As described previously [11, 12], the left atrial function can
be divided into three phases. For strain measurements, these
are defined as follows: (1) reservoir function was calculated as
maximal LAwall deformation during LV systole as compared
to the preset reference point (end diastole); (2) conduit func-
tion is considered the maximal LA wall deformation during
early LV diastole; and (3) contractile function is considered
as the maximal LA wall deformation during late LV diastole
(after the P wave on ECG). Consecutively, strain rate could
be calculated in these three different domains: reservoir,
conduit, and contractile function. To determine the effect
of the LAAA compared to the non-LAAA group, the delta
(before surgery to follow-up difference) of all parameters was
compared between groups.
2.5. Follow-Up. All patients visited the outpatient clinics
according to standard institutional protocol of care for
patients treated for AF and underwent a protocolled echocar-
diogram before surgery and at a median of 12 months (range
6–24 months) after surgery. Periprocedural adverse events
were registered. Due to the observational nature of the study,
no further specific investigation was requested from the
patients.
2.6. Endpoints. The primary endpoint was atrial function as
evaluated by strain, strain rate, and left atrial ejection fraction,
compared between groups. Secondary endpoints were LAAA
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Table 1: Baseline characteristics.
Non-LAAA group (𝑛 = 16) LAAA group (𝑛 = 16) 𝑝 value
Age, years 54 ± 10 59 ± 8 0.07
Male, 𝑛 (%) 14 (88%) 13 (81%) 0.63
Median AF history, years [range] 3 [1–10] 4 [1–15] 0.15
AF type
Paroxysmal, 𝑛 (%) 16 (100%) 16 (100%)
Previous catheter PVI, 𝑛 (%) 0 (0%) 1 (6%) 0.31
Catheter CTI ablation, 𝑛 (%) 1 (6%) 0 (0%) 0.31
CHA2DS2-VASC 0.14
0, 𝑛 (%) 7 (44%) 6 (38%)
1, 𝑛 (%) 7 (44%) 2 (12%)
≥2, 𝑛 (%) 2 (12%) 8 (50%)
Body mass index (kg/m2) 28 ± 4 27 ± 3 0.47
Body surface area (m2) 2.15 ± 0.18 2.10 ± 0.23 0.47
Hypertension, 𝑛 (%) 4 (25%) 7 (44%) 0.26
Diabetes, 𝑛 (%) 0 (0%) 1 (6%) 0.31
Stroke history, 𝑛 (%) 0 (0%) 2 (12%) 0.14
Systolic blood pressure (mmHg) 124 ± 19 142 ± 14 <0.01∗
Diastolic blood pressure (mmHg) 83 ± 18 82 ± 11 0.76
Heart rate (beats/min) 60 ± 9 64 ± 17 0.37
Echocardiography
LV ejection fraction (%) 59 ± 5 60 ± 7 0.90
LA ejection fraction (%) 40 ± 7 37 ± 10 0.41
LA diameter (mm) 42 ± 6 43 ± 6 0.61
LA volume (mL) 75 ± 15 89 ± 30 0.11
LA volume indexed (mL/m2) 35 ± 5 42 ± 11 0.06
LA strain measurements (%)
Reservoir function 29.2 ± 7.3 23.1 ± 7.6 0.03∗
Conduit function 16.1 ± 6.0 12.1 ± 4.9 0.05∗
Contraction function 13.2 ± 4.8 11.0 ± 5.0 0.22
LA strain rate measurements (s−1)
Reservoir function 1.15 ± 0.35 0.92 ± 0.19 0.03∗
Conduit function −1.20 ± 0.45 −0.97 ± 0.29 0.09
Contraction function −1.42 ± 0.46 −1.13 ± 0.44 0.08
∗
𝑝-value ≤ 0.05.
Table 2: Primary endpoints.
Parameter LAAA groupbaseline
LAAA group
follow-up
𝑝 value
within group
Non-LAAA
group baseline
Non-LAAA
group follow-up
𝑝 value
within group
Δ between
groups
Parasternal LAD (mm) 43 ± 6 43 ± 4 0.53 42 ± 6 44 ± 5 0.30 0.16
LAEF (%) 37 ± 10 37 ± 12 0.92 40 ± 7 37 ± 12 0.64 0.72
LAVI (LAV/BSA) 42 ± 11 41 ± 12 0.74 36 ± 5 36 ± 9 0.77 0.53
Strain reservoir (%) 23.1 ± 7.6 17.1 ± 4.6 <0.01∗ 29.2 ± 7.3 23.6 ± 6.3 <0.01∗ 0.70
Strain conduit (%) 12.1 ± 4.9 8.2 ± 3.5 0.01∗ 16.1 ± 6.0 11.6 ± 5.2 0.02∗ 0.47
Strain contraction (%) 11.0 ± 5.0 8.2 ± 3.3 0.07 13.2 ± 4.8 12.1 ± 4.1 0.15 0.18
Strain rate reservoir (s−1) 0.92 ± 0.19 0.79 ± 0.19 0.03∗ 1.15 ± 0.35 0.92 ± 0.31 0.02∗ 0.29
Strain rate conduit (s−1) −0.97 ± 0.29 −0.78 ± 0.35 0.11 −1.20 ± 0.45 −1.01 ± 0.35 0.053 0.94
Strain rate contraction (s−1) −1.13 ± 0.44 −0.93 ± 0.36 0.09 −1.42 ± 0.46 −1.27 ± 0.41 0.11 0.72
BSA = body surface area, LA = left atrium, LAEF = left atrial ejection fraction, LAD = left atrial diameter, PVF = pulmonary vein flow, LAV = left atrial volume,
LAVI = left atrial volume indexed, ∗𝑝 value ≤ 0.05.
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(1) Reservoir function was measured as maximal LA wall deformation during LV systole as compared to the preset reference point (end diastole)
(2) Conduit function is calculated as difference between measurement 1 and 3 
(3) Contractile function was measured as the maximal LA wall deformation during late LV diastole (after the P wave on ECG)
Longitudinal strain (%) Longitudinal strain rate (1/s)
Figure 1: Strain and strain rate measurements.
related adverse events and rhythm outcome at 12-month
follow-up without antiarrhythmic drugs.
2.7. Statistics. Baseline descriptive statistics are presented as
mean ± standard deviation or median (range) for continu-
ous variables, as appropriate, and counts with percentages
for categorical variables. Differences between subgroups, in
terms of patient characteristics at baseline, different follow-
up moments, and end of study, were evaluated by Student’s
𝑡-test or the Mann-Whitney 𝑈 test, depending on normality
of the data. Differences within subgroups were evaluated
using the Paired 𝑡-test. Chi-square or Fisher’s exact test was
used for comparison of categorical variables. The statistical
software package IBM SPSS Statistics version 22 was used for
all analysis.
3. Results
3.1. Patient Population. A total of 32 patients were treated
with sPVI for lone, drug refractory AF. Mean age was 57 ± 9
years; 84% were male. Paroxysmal AF was present in all 32
patients (100%) and the median AF duration was 3.5 years
(range 1–15). In the non-LAAA group 2 (13%) patients had a
CHADS2VASC score ≥ 2; in the LAAA group this number
was 8 (50%). Two patients underwent previous transcatheter
ablation; one patient underwent a cavotricuspid isthmus
ablation for a right-sided flutter; another patient underwent
transcatheter PVI for AF. The mean systolic and diastolic
blood pressure was 134± 19 and 82± 15mmHg, respectively.
The mean heart rate was 61 ± 10 beats per minute. Baseline
clinical patient characteristics did not differ significantly
between the two groups except for systolic blood pressure
(𝑝 = 0.005) (Table 1). Before surgery, ventricular diameters,
volume, and ejection fraction were similar between groups.
The left atrial indexed volume was enlarged with 42 ± 11
in the LAAA group versus 36 ± 5 in the non-LAAA group
(𝑝 = 0.06). Before surgery, strain rate reservoir function
differed significantly between groups (𝑝 = 0.026), but the
strain rate conduit and contraction function did not differ
between groups (𝑝 = 0.086 and 𝑝 = 0.079, resp.) (Table 1).
3.2. Surgical Treatment. In all patients, the sPVI procedure
was completed with proven acute block. Mean procedural
time was 160 ± 60 minutes. Mean hospitalization was 7 ± 2
days. The LAA was successfully excluded in all 16 patients
in whom LAA amputation was planned. This was objectified
by TEE after amputation of the LAA. No periprocedural
bleedings and, specifically, no LAAA related bleedings were
observed.
3.3. Left Atrial Function
3.3.1. LAAA Group. At a median of 12-month follow-up
echocardiography, the LA diameter and volume indexed
to BSA, in the LAAA group, was unchanged compared to
baselinemeasurements (𝑝 = 0.530,𝑝 = 0.646, and𝑝 = 0.735,
resp.). Compared to baseline, the strain measured at follow-
up of the reservoir and conduit but not contractile phase had
decreased (with 𝑝 = 0.007, 𝑝 = 0.014, and 𝑝 = 0.070, resp.).
In the strain rate domain, the reservoir function decreased
accordingly, but this was not observed in the conduit and
contractile phases (with 𝑝 values of 0.029, 0.109, and 0.092,
resp.) (Table 2 and Figure 2).
3.3.2. Non-LAAAGroup. At follow-up echocardiography, the
LA diameter and left atrial volume index of the LAAA group
was unchanged compared to baseline measurements (𝑝 =
0.301, 𝑝 = 0.478, and 𝑝 = 0.773, resp.). Compared to
baseline, the strain at follow-up had decreased in reservoir
and conduit but not in contractile function (𝑝 = 0.001,
𝑝 = 0.017, and 0.151, resp.). The strain rate of the reservoir
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Figure 2: Strain rate bar graph.
function decreased significantly whereas conduit and con-
tractile function did not, with 𝑝 values of 0.019, 0.053, and
0.108, respectively (Table 2 and Figure 2).
3.3.3. Comparison between Groups. When the delta (differ-
ence before surgery and follow-up measurements) is com-
pared between the LAAA and non-LAAA group, none of the
changes in atrial dimensions, atrial function, strain, or strain
rate measurements differed significantly (Table 2). Left atrial
ejection fraction did not differ significantly, neither within
nor between groups.
3.4. Follow-Up, Procedural Safety, and Rhythm Outcome. Of
all patients, pre- and postoperative echocardiography were
available and no patients were lost to follow-up. Echocardio-
graphy was conducted after a median of 12-month (range 6–
24) follow-up. In the LAAA group, no periprocedural (LAA)
bleeding occurred. In both investigated groups, 15 (94%)
patients were free from atrial arrhythmia and antiarrhythmic
medication at 12-month follow-up.
4. Discussion
In this retrospective, observational matched group com-
parison with a convenience sample size of 16 patients, the
findings suggest that amputation of the left atrial appendage
does not impair the contractile left atrial function or left
atrial ejection fraction in patients without structural heart
disease. However, the LA reservoir and conduit functions
were impaired significantly in both groups at follow-up
echocardiography.
Literature does not report the actual contribution of the
left atrial appendage to the atrial function ormore specifically
the contraction. Our study shows that the amputation of the
LAA does not significantly affect the left atrial contraction.
Our findings contrast with the previous report of Gelsomino
et al. who describe improved atrial function and reverse
remodeling after successful sPVI [17]. Left atrial volume
reduced significantly in these patients, whereas in our group
the dimensions did not. This difference might be explained
by the more extensive lesion set applied in the series of
Gelsomino et al., resulting in more scar related contracture
leading to a decrease in left atrial volume [17, 18]. Also, in
that series, 49% of patients underwent LAAA or closure; in
the other 51% the LAA was not addressed.
It is remarkable that the LA reservoir and conduit
function are impaired in both groups following minimally
invasive sPVI; this has not been reported previously and
might be contributable to the postoperative adhesions of the
6 BioMed Research International
pericardium and/or antral scarring due to the ablation. Fur-
thermore, it could be hypothesized that this impaired passive
left atrial function (conduit and reservoir) precedes active
(contractile) left atrial function impairment, as observed in
the left ventricle. More research on this topic is warranted.
In our patient population, the rhythm outcome was
excellent. This is contributable to our selected, relatively
young and healthy patient population with a short history
of highly symptomatic paroxysmal atrial fibrillation. Our
results are in accordance with the current literature on sPVI
procedures [19, 20]. In the present series, no periprocedural
bleeding was observed and, specifically, no LAAA related
bleedings. This notwithstanding, LAAA related bleedings
have been reported, due to the fragile and delicate wall of the
LAAA [21, 22].
It has previously been demonstrated that the left atrial
appendage is responsible for atrial natriuretic factor (ANF)
and performs an important physiologic function regulating
the intravascular volume via release of atrial natriuretic
peptide. In normal hearts, 30% of the ANF is contained in
the LAA. With appropriate medical therapies, postoperative
hypertension can be adequately managed, without residual
long-term hemodynamic effects.
For this study, we objectified the different left atrial
phases by tissue velocity imaging, speckle tracking method.
This technique was originally introduced to study left ven-
tricular function. As a spin-off, this technique has been
applied to the left atrium and several groups have showed
feasibility and good reproducibility in the setting of speckle
tracking on the left atrium [11, 23, 24]. As described, this
method provides new and interesting information on the left
atrial function, specifically reservoir, conduit, and contractile
function. However, it remains unclear in what quantities
the reservoir, conduit, and contractile phase contribute to
the ventricular filling. It also remains unknown what the
clinical effect of reduced conduit and reservoir function is,
especially in our specific young patient population without
major comorbidity. Further study is warranted on the subject
of left atrial function, both in healthy subjects and in the
context of atrial fibrillation ablation.
5. Conclusions
In this retrospective, observational matched group compari-
sonwith a convenience sample size of 16 patients, the findings
suggest that left atrial appendage amputation does not impair
the contractile left atrial function when compared to patients
in which the appendage was unaddressed. However, the left
atrial conduit and reservoir function decreased in both LAAA
and non-LAAA group following minimally invasive surgery
for AF. Our data suggest that the LAA can be removed
without late left atrial functional consequences.
Strengths and Limitations
Since a small number of patients were enrolled in this retro-
spective and observational study, no definite conclusions can
be drawn. Although matching provided similar patient char-
acteristics, there were differences between groups at baseline
when regarding strain and strain rate.This is counterbalanced
by the fact that consistent (echocardiographic) follow-up was
conducted and that comparisons are conducted both between
and within groups.
Disclosures
Dr. Stefano Benussi has a financial relationship with St. Jude
Medical Inc., AtriCure Inc., Medtronic Inc., CryoCath Inc.,
and Edwards Lifesciences Inc. Dr. Joris R. de Groot and Dr.
Antoine H. G. Driessen have a financial relationship with
AtriCure Inc.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
Acknowledgment
The authors thank Dr. B. Geelhoed for his statistical advice
and contribution to the figures.
References
[1] Y. Miyasaka, M. E. Barnes, B. J. Gersh et al., “Secular trends in
incidence of atrial fibrillation in Olmsted County, Minnesota,
1980 to 2000, and implications on the projections for future
prevalence,” Circulation, vol. 114, no. 2, pp. 119–125, 2006.
[2] A. J. Camm,G. Y. Lip, R.DeCaterina et al., “2012 focused update
of the ESCGuidelines for the management of atrial fibrillation,”
European Heart Journal, vol. 33, no. 21, pp. 2719–2747, 2012.
[3] R. Nieuwlaat, A. Capucci, A. J. Camm et al., “Atrial fibrillation
management: a prospective survey in ESC member countries:
the Euro Heart Survey on Atrial Fibrillation,” European Heart
Journal, vol. 26, no. 22, pp. 2422–2434, 2005.
[4] S. P. J. Krul, A. H. G. Driessen, A. H. Zwinderman et al.,
“Navigating themini-maze: Systematic review of the first results
and progress of minimally-invasive surgery in the treatment of
atrial fibrillation,” International Journal of Cardiology, vol. 166,
no. 1, pp. 132–140, 2013.
[5] A. Yilmaz, B. P. van Putte, and W. J. van Boven, “Completely
thoracoscopic bilateral pulmonary vein isolation and left atrial
appendage exclusion for atrial fibrillation,” Journal of Thoracic
and Cardiovascular Surgery, vol. 136, no. 2, pp. 521–522, 2008.
[6] J. A. Odell, J. L. Blackshear, E. Davies et al., “Thoracoscopic
obliteration of the left atrial appendage: potential for stroke
reduction?” Annals of Thoracic Surgery, vol. 61, no. 2, pp. 565–
569, 1996.
[7] J. Dunning, M. Nagendran, O. R. Alfieri et al., “Guideline for
the surgical treatment of atrial fibrillation,” European Journal of
Cardio-Thoracic Surgery, vol. 44, no. 5, pp. 777–791, 2013.
[8] C. T. January, L. S. Wann, J. S. Alpert et al., “2014
AHA/ACC/HRS Guideline for the management of patients
with atrial fibrillation,” Journal of the American College of
Cardiology, vol. 64, no. 21, pp. e1–e76, 2014.
[9] M. Y. Emmert, G. Puippe, S. Baumu¨ller et al., “Safe, effective and
durable epicardial left atrial appendage clip occlusion in patients
with atrial fibrillation undergoing cardiac surgery: first long-
term results from a prospective device trial,” European Journal
of Cardio-Thoracic Surgery, vol. 45, no. 1, pp. 126–131, 2014.
BioMed Research International 7
[10] P. Debonnaire, D. P. Leong, T. G. Witkowski et al., “Left
atrial function by two-dimensional speckle-tracking echocar-
diography in patients with severe organic mitral regurgitation:
association with guidelines-based surgical indication and post-
operative (long-term) survival,” Journal of the American Society
of Echocardiography, vol. 26, no. 9, pp. 1053–1062, 2013.
[11] V. Mor-Avi, R. M. Lang, L. P. Badano et al., “Current and evolv-
ing echocardiographic techniques for the quantitative evalua-
tion of cardiac mechanics: ASE/EAE consensus statement on
methodology and indications endorsed by the Japanese society
of echocardiography,” European Journal of Echocardiography,
vol. 12, no. 3, pp. 167–205, 2011.
[12] R. Ancona, S. C. Pinto, P. Caso et al., “Left atriumby echocardio-
graphy in clinical practice: from conventional methods to new
echocardiographic techniques,” The Scientific World Journal,
vol. 2014, Article ID 451042, 15 pages, 2014.
[13] G. E. de Maat, I. C. van Gelder, M. Rienstra et al., “Surgical
vs. transcatheter pulmonary vein isolation as first invasive
treatment in patients with atrial fibrillation: a matched group
comparison,” Europace, vol. 16, no. 1, pp. 33–39, 2014.
[14] H. Calkins, K. H. Kuck, R. Cappato et al., “2012 HRS/EHRA/
ECAS expert consensus statement on catheter and surgical abla-
tion of atrial fibrillation: recommendations for patient selection,
procedural techniques, patient management and follow-up,
definitions, endpoints, and research trial design,” Europace, vol.
14, no. 4, pp. 528–606, 2012.
[15] S. P. J. Krul, A. H. G. Driessen, W. J. van Boven et al.,
“Thoracoscopic video-assisted pulmonary vein antrum isola-
tion, ganglionated plexus ablation, and periprocedural confir-
mation of ablation lesions: first results of a hybrid surgical-
electrophysiological approach for atrial fibrillation,” Circula-
tion: Arrhythmia and Electrophysiology, vol. 4, no. 3, pp. 262–
270, 2011.
[16] M. La Meir, S. Gelsomino, F. Luca` et al., “Improvement of left
atrial function and left atrial reverse remodeling afterminimally
invasive radiofrequency ablation evaluated by 2-dimensional
speckle tracking echocardiography,” Journal of Thoracic and
Cardiovascular Surgery, vol. 146, no. 1, pp. 72–77, 2013.
[17] S. Gelsomino, F. Luca, C. M. Rao et al., “Improvement of
left atrial function and left atrial reverse remodeling after
surgical treatment of atrial fibrillation,”Annals of Cardiothoracic
Surgery, vol. 3, no. 1, pp. 70–74, 2014.
[18] I. E. Hof, B. K. Velthuis, S.-M. Chaldoupi et al., “Pulmonary vein
antrum isolation leads to a significant decrease of left atrial size,”
Europace, vol. 13, no. 3, pp. 371–375, 2011.
[19] V. Kasirajan, E. A. Spradlin, T. E. Mormando et al., “Minimally
invasive surgery using bipolar radiofrequency energy is effective
treatment for refractory atrial fibrillation,” Annals of Thoracic
Surgery, vol. 93, no. 5, pp. 1456–1461, 2012.
[20] M. Santini, V. Loiaconi, M. P. Tocco, F. Mele, and C. Pandozi,
“Feasibility and efficacy of minimally invasive stand-alone sur-
gical ablation of atrial fibrillation. A single-center experience,”
Journal of Interventional Cardiac Electrophysiology, vol. 34, no.
1, pp. 79–87, 2012.
[21] J. S. Healey, E. Crystal, A. Lamy et al., “Left Atrial Appendage
Occlusion Study (LAAOS): results of a randomized controlled
pilot study of left atrial appendage occlusion during coronary
bypass surgery in patients at risk for stroke,” American Heart
Journal, vol. 150, no. 2, pp. 288–293, 2005.
[22] G. E. de Maat, A. Pozzoli, M. F. Scholten et al., “Surgical
minimally invasive pulmonary vein isolation for lone atrial
fibrillation:midterm results of amulticenter study,” Innovations:
Technology and Techniques in Cardiothoracic and Vascular
Surgery, vol. 8, no. 6, pp. 410–415, 2013.
[23] M. Cameli, M. Caputo, S. Mondillo et al., “Feasibility and
reference values of left atrial longitudinal strain imaging by two-
dimensional speckle tracking,” Cardiovascular Ultrasound, vol.
7, no. 1, article 6, 2009.
[24] R. M. Saraiva, S. Demirkol, A. Buakhamsri et al., “Left atrial
strain measured by two-dimensional speckle tracking repre-
sents a new tool to evaluate left atrial function,” Journal of the
American Society of Echocardiography, vol. 23, no. 2, pp. 172–
180, 2010.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
